Aprecia to invest $25M in Ohio plant; UN accuses Chinese drugmakers of aiding meth trade; Novartis touts efficiency gains from packaging tech;

> Aprecia Pharmaceuticals is to invest $25 million to turn a vacant building in Ohio into a production plant staffed by 150 people. More

> A United Nations official has accused corrupt elements of the Chinese pharmaceutical industry of supplying methamphetamine manufacturers with precursor chemicals. Article

> Novartis ($NVS) has explained how an investment in packaging technology allowed its plant in Cairo, India, to manufacture a wider range of products. Feature

> Nigerian regulators have destroyed counterfeit pharmaceuticals with an estimated value of $2.5 million. News

> Akorn Pharmaceuticals ($AKRX) has become the latest drugmaker to speak out against the use of midazolam for executions. The manufacturer will now only ship midazolam to a select group of wholesalers. Piece

Suggested Articles

Life sciences companies have pivoted quickly during COVID-19 - Syneos Health® is supporting more than 80 active COVID-19 projects, including vaccines.

New York's Covaxx has signed on with three South American nations to provide 140 million doses of its early-stage COVID-19 vaccine.

CureVac has tapped Wacker to help produce 100 million doses of its mRNA-based COVID-19 vaccine at its Amsterdam facility.